Medically reviewed on March 9, Fexofenadine-pseudoephedrine has been assigned to pregnancy category C by the FDA. Reproductive studies in rats and rabbits have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy. Fexofenadine-pseudoephedrine should only be given during pregnancy when there are no alternatives and benefit outweighs risk. There are no data on the excretion of fexofenadine into human milk. Pseudoephedrine is excreted into human milk.
Three mothers given pseudoephedrine demonstrated milk concentrations consistently higher than plasma concentrations.
Maximum milk concentrations were reached at 1 to 1. In one woman, the milk: The authors calculated that mL of breast milk consumed over 24 hours would provide an infant with 0.
There are no reports of adverse effects in infants who were exposed to pseudoephedrine in breast milk. The American Academy of Pediatrics considers pseudoephedrine to be compatible with breast-feeding. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. By clicking Subscribe, I agree to the Drugs. The easiest way to lookup drug information, identify pills, allegra d and pregnancy interactions and set allegra d and pregnancy your own personal medication records.
Available for Android and iOS devices, allegra d and pregnancy. Subscribe to receive email notifications whenever new articles are published. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
To view content sources and attributions, please refer to our editorial policy. We comply with the HONcode standard for trustworthy health information - verify here. Publishing Sciences Group, Inc. References for breastfeeding information Committee on Drugs, to "The transfer of drugs and other chemicals into human milk, allegra d and pregnancy. Subscribe to free Drugs. FDA alerts for all medications.